NRIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,215,543.67

Nurix Therapeutics Insider Trading History Chart

Nurix Therapeutics Share Price & Price History

^$22.92

▼ -3.94 (-14.67%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Nurix Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2024	Houte Hans Van	CFO	Sell	3,546	$24.28	$86,096.88	33,724
10/30/2024	Gwenn Hansen	Insider	Sell	3,437	$24.30	$83,519.10	50,670
10/30/2024	Houte Hans Van	CFO	Sell	2,368	$24.30	$57,542.40	37,270
10/14/2024	Christine Ring	Insider	Sell	3,290	$25.00	$82,250.00	24,592
10/1/2024	Christine Ring	Insider	Sell	5,760	$22.23	$128,044.80	24,592
9/3/2024	Christine Ring	Insider	Sell	9,050	$24.94	$225,707.00	24,592
8/26/2024	Christine Ring	Insider	Sell	9,870	$25.01	$246,848.70	24,592
8/26/2024	Houte Hans Van	CFO	Sell	20,000	$25.22	$504,400.00	31,002
8/1/2024	Christine Ring	Insider	Sell	5,760	$21.43	$123,436.80	24,592
8/1/2024	Houte Hans Van	CFO	Sell	3,477	$21.45	$74,581.65	51,002
7/30/2024	Gwenn Hansen	Insider	Sell	3,408	$20.67	$70,443.36	45,150
7/30/2024	Houte Hans Van	CFO	Sell	2,490	$20.67	$51,468.30	54,479
7/1/2024	Christine Ring	Insider	Sell	5,760	$20.81	$119,865.60	19,838
6/12/2024	Christine Ring	Insider	Sell	1,900	$17.01	$32,319.00	19,838
6/5/2024	Christine Ring	Insider	Sell	400	$17.00	$6,800.00	19,838
6/3/2024	Christine Ring	Insider	Sell	1,596	$17.01	$27,147.96	19,838
5/2/2024	Houte Hans Van	CFO	Sell	3,499	$12.83	$44,892.17	68,333
4/30/2024	Gwenn Hansen	Insider	Sell	2,007	$12.04	$24,164.28	39,601
4/30/2024	Houte Hans Van	CFO	Sell	1,387	$12.04	$16,699.48	71,832
2/16/2024	Houte Hans Van	CFO	Sell	6,812	$10.02	$68,256.24	68,333
1/30/2024	Gwenn Hansen	Insider	Sell	2,334	$7.99	$18,648.66	36,402
1/30/2024	Houte Hans Van	CFO	Sell	1,671	$7.99	$13,351.29	75,145
12/19/2023	Houte Hans Van	CFO	Sell	10,906	$10.00	$109,060.00	75,471
10/31/2023	Christine Ring	Insider	Sell	1,232	$5.20	$6,406.40	15,263
10/31/2023	Houte Hans Van	CFO	Sell	1,080	$5.20	$5,616.00	86,377
7/31/2023	Christine Ring	General Counsel	Sell	1,420	$9.65	$13,703.00	12,544
7/31/2023	Gwenn Hansen	Insider	Sell	1,884	$9.65	$18,180.60	29,955
7/31/2023	Houte Hans Van	CFO	Sell	1,245	$9.65	$12,014.25	82,571
5/1/2023	Christine Ring	General Counsel	Sell	682	$9.88	$6,738.16	10,040
5/1/2023	Gwenn Hansen	Insider	Sell	1,136	$9.88	$11,223.68	26,632
5/1/2023	Houte Hans Van	CFO	Sell	721	$9.88	$7,123.48	78,930
5/1/2023	Stefani Wolff	COO	Sell	342	$9.88	$3,378.96	6,113
1/30/2023	Christine Ring	General Counsel	Sell	848	$11.78	$9,989.44	7,261
1/30/2023	Gwenn Hansen	Insider	Sell	1,412	$11.78	$16,633.36	23,009
1/30/2023	Houte Hans Van	CFO	Sell	924	$11.78	$10,884.72	76,765
1/30/2023	Stefani Wolff	COO	Sell	424	$11.78	$4,994.72	3,940
10/31/2022	Christine Ring	General Counsel	Sell	699	$12.88	$9,003.12	6,185
10/31/2022	Gwenn Hansen	Insider	Sell	1,165	$12.88	$15,005.20	21,214
10/31/2022	Houte Hans Van	CFO	Sell	739	$12.88	$9,518.32	74,803
10/31/2022	Stefani Wolff	COO	Sell	350	$12.88	$4,508.00	3,402
8/1/2022	Christine Ring	General Counsel	Sell	712	$15.67	$11,157.04	4,615
8/1/2022	Gwenn Hansen	Insider	Sell	1,186	$15.67	$18,584.62	19,172
8/1/2022	Houte Hans Van	CFO	Sell	752	$15.67	$11,783.84	72,656
8/1/2022	Stefani Wolff	COO	Sell	356	$15.67	$5,578.52	1,238
5/2/2022	Christine Ring	General Counsel	Sell	660	$11.75	$7,755.00	3,403
5/2/2022	Gwenn Hansen	Insider	Sell	1,098	$11.75	$12,901.50	17,151
5/2/2022	Houte Hans Van	CFO	Sell	697	$11.75	$8,189.75	2,189
5/2/2022	Stefani Wolff	COO	Sell	330	$11.75	$3,877.50	632
12/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.04	$34,848.00
12/1/2021	Gwenn Hansen	Insider	Sell	400	$29.13	$11,652.00

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

SEC Filings (Institutional Ownership Changes) for Nurix Therapeutics (NASDAQ:NRIX)

Institutional Buying and Selling by Quarter

Nurix Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,448,040	$32.54M	0.0%	+9.6%	2.044%
11/15/2024	Barclays PLC	128,344	$2.88M	0.0%	+77.9%	0.181%
11/15/2024	Y Intercept Hong Kong Ltd	15,388	$0.35M	0.0%	N/A	0.022%
11/15/2024	EP Wealth Advisors LLC	10,693	$0.24M	0.0%	N/A	0.015%
11/15/2024	Jane Street Group LLC	157,619	$3.54M	0.0%	-21.2%	0.223%
11/15/2024	Wellington Management Group LLP	3,482,105	$78.24M	0.0%	+8.8%	4.915%
11/15/2024	State Street Corp	2,371,271	$53.28M	0.0%	-12.5%	3.347%
11/15/2024	Quarry LP	2,500	$56K	0.0%	+3,746.2%	0.004%
11/15/2024	Redmile Group LLC	4,280,981	$96.19M	5.7%	-3.2%	6.043%
11/15/2024	Polar Asset Management Partners Inc.	27,000	$0.61M	0.0%	N/A	0.038%
11/15/2024	Parkman Healthcare Partners LLC	438,971	$9.86M	1.3%	-7.5%	0.620%
11/15/2024	Patient Square Capital LP	325,789	$7.32M	2.7%	N/A	0.460%
11/15/2024	Ikarian Capital LLC	260,000	$5.84M	0.8%	-41.0%	0.367%
11/15/2024	Cinctive Capital Management LP	105,228	$2.36M	0.1%	N/A	0.149%
11/14/2024	Bellevue Group AG	8,000	$0.18M	0.0%	N/A	0.011%
11/14/2024	Wasatch Advisors LP	708,377	$15.92M	0.1%	-17.4%	1.000%
11/14/2024	Fred Alger Management LLC	166,014	$3.73M	0.0%	+336.1%	0.234%
11/14/2024	Vestal Point Capital LP	425,000	$9.55M	0.7%	-15.0%	0.600%
11/13/2024	FMR LLC	586,902	$13.19M	0.0%	+675.9%	0.828%
11/13/2024	The Manufacturers Life Insurance Company	30,383	$0.68M	0.0%	+32.4%	0.043%
11/13/2024	Dynamic Technology Lab Private Ltd	23,578	$0.53M	0.1%	N/A	0.033%
11/12/2024	Charles Schwab Investment Management Inc.	511,720	$11.50M	0.0%	-17.9%	0.722%
11/12/2024	Massachusetts Financial Services Co. MA	69,415	$1.56M	0.0%	-29.3%	0.098%
11/9/2024	Intech Investment Management LLC	18,901	$0.43M	0.0%	N/A	0.027%
11/7/2024	Quest Partners LLC	7,458	$0.17M	0.0%	+21.3%	0.011%
11/5/2024	Victory Capital Management Inc.	21,540	$0.48M	0.0%	N/A	0.030%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	553,251	$12.43M	0.0%	N/A	0.781%
11/5/2024	GSA Capital Partners LLP	10,667	$0.24M	0.0%	-58.7%	0.015%
11/4/2024	Los Angeles Capital Management LLC	26,544	$0.60M	0.0%	-20.2%	0.037%
10/31/2024	ARK Investment Management LLC	2,216,365	$49.80M	0.5%	-4.6%	3.129%
10/30/2024	Amalgamated Bank	2,182	$49K	0.0%	+30.6%	0.003%
10/25/2024	China Universal Asset Management Co. Ltd.	12,388	$0.28M	0.0%	+77.8%	0.017%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,330	$54K	0.0%	+31.6%	0.005%
10/22/2024	International Assets Investment Management LLC	4,494	$0.10M	0.0%	+1,098.4%	0.009%
10/19/2024	Allspring Global Investments Holdings LLC	140,273	$3.15M	0.0%	N/A	0.285%
10/18/2024	WestHill Financial Advisors Inc.	238,333	$5.36M	1.2%	-15.9%	0.485%
10/10/2024	Exchange Traded Concepts LLC	6,583	$0.15M	0.0%	-57.5%	0.013%
10/3/2024	SG Americas Securities LLC	22,945	$0.52M	0.0%	-77.8%	0.047%
8/26/2024	Teachers Retirement System of The State of Kentucky	27,695	$0.58M	0.0%	N/A	0.056%
8/16/2024	Driehaus Capital Management LLC	1,283,108	$26.78M	0.3%	N/A	2.611%
8/15/2024	Susquehanna Portfolio Strategies LLC	155,984	$3.26M	0.1%	-1.4%	0.317%
8/15/2024	The Manufacturers Life Insurance Company	22,942	$0.48M	0.0%	+25.0%	0.047%
8/15/2024	Millennium Management LLC	599,623	$12.51M	0.0%	+60.2%	1.220%
8/15/2024	Dark Forest Capital Management LP	9,609	$0.20M	0.0%	N/A	0.020%
8/15/2024	Deerfield Management Company L.P. Series C	27,507	$0.57M	0.0%	+66.5%	0.056%
8/15/2024	AQR Capital Management LLC	21,296	$0.44M	0.0%	+76.8%	0.043%
8/15/2024	Affinity Asset Advisors LLC	912,000	$19.03M	2.2%	+12.6%	1.856%
8/15/2024	Alpha DNA Investment Management LLC	20,440	$0.43M	0.2%	N/A	0.042%
8/15/2024	Caxton Associates LP	30,767	$0.64M	0.0%	+100.9%	0.063%
8/14/2024	Squarepoint Ops LLC	28,784	$0.60M	0.0%	N/A	0.059%
8/14/2024	Fred Alger Management LLC	38,066	$0.79M	0.0%	N/A	0.077%
8/14/2024	Samlyn Capital LLC	583,490	$12.18M	0.2%	N/A	1.187%
8/14/2024	Farallon Capital Management LLC	108,799	$2.27M	0.0%	N/A	0.221%
8/14/2024	Integral Health Asset Management LLC	150,000	$3.13M	0.3%	N/A	0.305%
8/14/2024	ProShare Advisors LLC	10,037	$0.21M	0.0%	-16.2%	0.020%
8/14/2024	Profund Advisors LLC	25,588	$0.53M	0.0%	-22.6%	0.052%
8/13/2024	Ensign Peak Advisors Inc	35,644	$0.74M	0.0%	-55.4%	0.073%
8/12/2024	XTX Topco Ltd	15,729	$0.33M	0.0%	-40.3%	0.032%
8/12/2024	Hsbc Holdings PLC	17,038	$0.35M	0.0%	-49.4%	0.035%
8/9/2024	Primecap Management Co. CA	290,000	$6.05M	0.0%	+3.9%	0.590%
8/9/2024	Renaissance Technologies LLC	324,000	$6.76M	0.0%	+80.7%	0.659%
8/9/2024	Dimensional Fund Advisors LP	603,133	$12.59M	0.0%	-37.6%	1.227%
8/9/2024	Massachusetts Financial Services Co. MA	98,171	$2.05M	0.0%	-13.0%	0.200%
8/8/2024	American Century Companies Inc.	10,124	$0.21M	0.0%	-83.1%	0.021%
8/7/2024	ClariVest Asset Management LLC	63,149	$1.32M	0.1%	+2.9%	0.128%
8/6/2024	Quest Partners LLC	6,146	$0.13M	0.0%	-33.0%	0.013%
8/6/2024	Acadian Asset Management LLC	115,341	$2.41M	0.0%	-28.0%	0.235%
8/6/2024	Los Angeles Capital Management LLC	33,245	$0.69M	0.0%	-67.5%	0.068%
8/6/2024	Candriam S.C.A.	1,164,246	$24.30M	0.1%	+30.5%	2.369%
8/5/2024	Arizona State Retirement System	14,114	$0.30M	0.0%	N/A	0.029%
8/3/2024	TD Asset Management Inc	28,434	$0.59M	0.0%	N/A	0.044%
8/1/2024	Rhumbline Advisers	88,781	$1.85M	0.0%	+14.2%	0.138%
7/31/2024	nVerses Capital LLC	1,600	$33K	0.0%	-69.2%	0.002%
7/30/2024	RAM Investment Partners LLC	17,284	$0.36M	0.1%	N/A	0.035%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	15,207	$0.32M	0.0%	+762.6%	0.024%
7/26/2024	ARK Investment Management LLC	2,323,332	$48.49M	0.4%	-11.8%	3.607%
7/26/2024	Bank of New York Mellon Corp	209,136	$4.37M	0.0%	+31.4%	0.325%
7/12/2024	SG Americas Securities LLC	103,199	$2.15M	0.0%	+365.0%	0.210%
7/2/2024	GAMMA Investing LLC	4,566	$95K	0.0%	+299.8%	0.009%
5/29/2024	Opaleye Management Inc.	267,210	$3.93M	0.9%	N/A	0.544%
5/17/2024	Ikarian Capital LLC	300,000	$4.41M	0.5%	N/A	0.610%
5/16/2024	California State Teachers Retirement System	4,786	$70K	0.0%	-38.9%	0.010%
5/16/2024	Jacobs Levy Equity Management Inc.	434,413	$6.39M	0.0%	+73.5%	0.884%
5/16/2024	Kennedy Capital Management LLC	88,260	$1.30M	0.0%	-45.2%	0.180%
5/16/2024	Bain Capital Life Sciences Investors LLC	1,132,397	$16.65M	1.3%	-37.9%	2.304%
5/16/2024	Caxton Associates LP	15,314	$0.23M	0.0%	N/A	0.031%
5/16/2024	Redmile Group LLC	4,483,016	$65.90M	2.4%	+37.7%	9.121%
5/15/2024	Public Employees Retirement System of Ohio	50,838	$0.75M	0.0%	+3.7%	0.103%
5/15/2024	Price T Rowe Associates Inc. MD	2,196,169	$32.28M	0.0%	-8.1%	4.468%
5/15/2024	Affinity Asset Advisors LLC	810,253	$11.91M	1.5%	+17.4%	1.649%
5/14/2024	EntryPoint Capital LLC	8,335	$0.12M	0.1%	N/A	0.017%
5/10/2024	Acadian Asset Management LLC	160,293	$2.36M	0.0%	+576.7%	0.326%
5/10/2024	Vanguard Group Inc.	2,584,300	$37.99M	0.0%	-0.5%	5.258%
5/8/2024	ProShare Advisors LLC	11,978	$0.18M	0.0%	+9.1%	0.024%
5/8/2024	Russell Investments Group Ltd.	53,542	$0.79M	0.0%	+75.6%	0.109%
5/7/2024	49 Wealth Management LLC	12,503	$0.18M	0.0%	-8.7%	0.025%
5/7/2024	SG Americas Securities LLC	22,194	$0.33M	0.0%	-16.6%	0.045%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	30,904	$0.45M	0.0%	+27.3%	0.063%
4/30/2024	J.W. Cole Advisors Inc.	18,028	$0.27M	0.0%	N/A	0.037%
4/29/2024	Principal Financial Group Inc.	12,953	$0.19M	0.0%	-8.4%	0.026%

Data available starting January 2016

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and cell therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc., Sanofi S.A., and Seagen Inc. co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

Today's Range

Now: $22.92

$22.88

$26.62

50 Day Range

MA: $24.54

$21.54

$28.14

52 Week Range

Now: $22.92

$5.65

$29.56

Volume

1,692,500 shs

Average Volume

902,645 shs

Market Capitalization

$1.62 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.2

Who are the company insiders with the largest holdings of Nurix Therapeutics?: Nurix Therapeutics' top insider investors include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Christine Ring (Insider)
Christine Ring (General Counsel)
Stefani Wolff (COO)
Learn More about top insider investors at Nurix Therapeutics.
Who are the major institutional investors of Nurix Therapeutics?: Nurix Therapeutics' top institutional investors include:
Redmile Group LLC — 6.04%
Wellington Management Group LLP — 4.92%
State Street Corp — 3.35%
ARK Investment Management LLC — 3.13%
Geode Capital Management LLC — 2.04%
Wasatch Advisors LP — 1.00%
Learn More about top institutional investors of Nurix Therapeutics stock.
Which institutional investors are selling Nurix Therapeutics stock?: During the last quarter, NRIX stock was sold by these institutional investors:
State Street Corp
Ikarian Capital LLC
Wasatch Advisors LP
Redmile Group LLC
Charles Schwab Investment Management Inc.
ARK Investment Management LLC
SG Americas Securities LLC
Vestal Point Capital LP
Within the last year, company insiders that have sold Nurix Therapeutics company stock include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Christine Ring (Insider)
Learn More investors selling Nurix Therapeutics stock.
Which institutional investors are buying Nurix Therapeutics stock?: Within the previous quarter, NRIX stock was purchased by institutional investors including:
Sumitomo Mitsui Trust Group Inc.
FMR LLC
Patient Square Capital LP
Wellington Management Group LLP
Allspring Global Investments Holdings LLC
Fred Alger Management LLC
Geode Capital Management LLC
Cinctive Capital Management LP